AngioDynamics, Inc. (ANGO) is set to report earnings on 10/02/2025, with a forecasted EPS of $-0.14 for the quarter ending August 31, 2025. This marks a 27.27% decrease from the same period last year. In the past year, ANGO has consistently beat expectations, with a notable 76.92% beat in the 2nd quarter. Zacks Investment Research indicates a 2026 P/E ratio of -37.23 for ANGO, compared to the industry ratio of 7.60.

Read more at Nasdaq: Pre-Market Earnings Report for October 2, 2025 : ANGO